[go: up one dir, main page]

EP0662834A4 - Novel epoxide-containing compounds. - Google Patents

Novel epoxide-containing compounds.

Info

Publication number
EP0662834A4
EP0662834A4 EP93922366A EP93922366A EP0662834A4 EP 0662834 A4 EP0662834 A4 EP 0662834A4 EP 93922366 A EP93922366 A EP 93922366A EP 93922366 A EP93922366 A EP 93922366A EP 0662834 A4 EP0662834 A4 EP 0662834A4
Authority
EP
European Patent Office
Prior art keywords
containing compounds
novel epoxide
epoxide
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93922366A
Other languages
German (de)
French (fr)
Other versions
EP0662834A1 (en
Inventor
Gail Underiner
J Peter Klein
John Michnick
Alistair Leigh
Anil Kumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CTI Biopharma Corp
Original Assignee
Cell Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/949,330 external-priority patent/US5288721A/en
Application filed by Cell Therapeutics Inc filed Critical Cell Therapeutics Inc
Publication of EP0662834A1 publication Critical patent/EP0662834A1/en
Publication of EP0662834A4 publication Critical patent/EP0662834A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP93922366A 1992-09-22 1993-09-22 Novel epoxide-containing compounds. Withdrawn EP0662834A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US949330 1992-09-22
US07/949,330 US5288721A (en) 1992-09-22 1992-09-22 Substituted epoxyalkyl xanthines
US99165592A 1992-12-16 1992-12-16
US991655 1992-12-16
PCT/US1993/009073 WO1994006431A1 (en) 1992-09-22 1993-09-22 Novel epoxide-containing compounds

Publications (2)

Publication Number Publication Date
EP0662834A1 EP0662834A1 (en) 1995-07-19
EP0662834A4 true EP0662834A4 (en) 1996-04-17

Family

ID=27130287

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93922366A Withdrawn EP0662834A4 (en) 1992-09-22 1993-09-22 Novel epoxide-containing compounds.

Country Status (5)

Country Link
EP (1) EP0662834A4 (en)
JP (1) JPH08501564A (en)
AU (1) AU5138493A (en)
CA (1) CA2145192A1 (en)
WO (1) WO1994006431A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620739A4 (en) * 1992-09-15 1997-01-15 Immunex Corp Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists.
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
EP0739203A4 (en) * 1994-01-14 2000-12-20 Cell Therapeutics Inc Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf
JPH09511496A (en) * 1994-02-18 1997-11-18 セル・セラピューティックス・インコーポレーテッド Intracellular messenger
WO1998052919A1 (en) * 1997-05-21 1998-11-26 Japan Tobacco Inc. Phthalimide derivatives and pharmaceutical containing said derivatives
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
US6946465B2 (en) 1999-02-02 2005-09-20 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
WO2008009078A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
HUE038059T2 (en) 2015-03-04 2018-10-29 Gilead Sciences Inc Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
US10370342B2 (en) 2016-09-02 2019-08-06 Gilead Sciences, Inc. Toll like receptor modulator compounds
ES2826748T3 (en) 2016-09-02 2021-05-19 Gilead Sciences Inc Derivatives of 4,6-diamino-pyrido [3,2-d] pyrimidine as modulators of Toll-like receptors
TW202210480A (en) 2019-04-17 2022-03-16 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TWI751517B (en) 2019-04-17 2022-01-01 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TWI879779B (en) 2019-06-28 2025-04-11 美商基利科學股份有限公司 Processes for preparing toll-like receptor modulator compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE678272A (en) * 1965-03-23 1966-09-23 Ciba Ltd

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158967A (en) * 1991-06-12 1992-10-27 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE678272A (en) * 1965-03-23 1966-09-23 Ciba Ltd

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 100, no. 1, 2 January 1984, Columbus, Ohio, US; abstract no. 6860k, page 593; column L; *
INDIAN JOURNAL OF CHEMISTRY., SECTION B, vol. 22B, no. 5, 1983, pages 515 - 516 *
See also references of WO9406431A1 *

Also Published As

Publication number Publication date
JPH08501564A (en) 1996-02-20
WO1994006431A1 (en) 1994-03-31
EP0662834A1 (en) 1995-07-19
AU5138493A (en) 1994-04-12
CA2145192A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
ZA92908B (en) Compounds.
EP0597463A3 (en) Thermotherapiesonde.
EP0598412A3 (en) Skinprotection composition.
EP0580285A3 (en) Auto-reclosers.
ZA939656B (en) Microvicidal compositions.
EP0605089A3 (en) Photoresist composition.
EP0671929A4 (en) Compositions.
EP0633771A4 (en) Compounds.
ZA929517B (en) Compounds.
ZA931773B (en) Substituted phenylacetamides.
EP0662834A4 (en) Novel epoxide-containing compounds.
EP0603314A4 (en) Chemical compounds.
ZA931772B (en) Imidazolyl-substituted phenylacetamides.
DE69205795D1 (en) Mesoprotheseunterlage.
EP0599191A3 (en) Speed-governor-circuit.
EP0653937A4 (en) Chemical compounds.
EP0592354A3 (en) Vacuum-centrifuge.
ZA925725B (en) Qinolin-2-yl-methoxybenzylhydroxyureas.
GR3034333T3 (en) Antifoaming agents.
EP0536310A4 (en) Chemical compounds.
GR3017775T3 (en) Phenoxy-heterocyclic compounds.
ZA935828B (en) New insobutyl-substituted methanesulphonyl-quinolyl-methoxyphenyl-cycloalkylacetamides.
EP0624089A4 (en) Methods.
EP0671924A4 (en) Digitalis-like compounds.
DE59200703D1 (en) Polyketomethinfarbstoffe.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950407

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19960301

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990401